Investing in the Future of Healthcare
DaVita Venture Group invests in, acquires, and co-develops solutions that improve clinical outcomes and patient experiences. Our goal is to transform kidney care through strategic innovation.
Our Investment Priorities
Care Models
Tech-enabled services, home treatments and value-based care
Digital Health
Data and artificial intelligence to improve care delivery
New Service Lines
Extending DaVita’s clinical excellence to adjacent verticals of care
Life Sciences
Pharma, devices and diagnostics that improve clinical outcomes and reduce costs
Our investments slow kidney disease progression, support poly-chronic disease management, and accelerate innovation from initial diagnosis to transplant
All capital comes from DaVita. We take an active strategic role to contribute clinical and operational expertise, product development resources, data insights and more.
Venture Capital:
Invest up to $10M in Series A and beyond
Corporate Development:
Execute scale investments and joint ventures
Partnerships:
Co-develop, pilot, and integrate care models & technologies
Portfolio
Meet Our Team
Contact Us
Interested in working with DaVita Venture Group? Reach out to our team directly.